ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

    公开(公告)号:US20250160194A1

    公开(公告)日:2025-05-15

    申请号:US19013100

    申请日:2025-01-08

    Abstract: A compound having a formula of Ir(LA)n(LB)m(LC)o is provided, where LA has a structure of Formula IA, LB has a structure of Formula IB, and LC is a bidentate ligand. In formula Ir(LA)n(LB)m(LC)o, Formula IA, and Formula IB: m, n, and o are integers and their sum is 3; each of Z1, Z2, Z3, Z4, and X1 to X12 is C or N; each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; the ring comprising Z3 and Z4 is a 5-membered heterocyclic ring; Y is as linking group; each R, R′, R″, R1, R2, R3, R4, and R5 is hydrogen or a General Substituent; and at least one pair of R1 or one pair of R2 are joined to form moiety I, which is a heterocyclic moiety. Formulations, OLEDs, and consumer products containing the compound are also provided.

    ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

    公开(公告)号:US20250109160A1

    公开(公告)日:2025-04-03

    申请号:US18781350

    申请日:2024-07-23

    Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of moieties A, B, C, and D are a monocyclic ring or a polycyclic fused ring system; Z is N, P, B, CR, SiR, or GeR; each of Z1 to Z10 is independently C or N; each of K1 and K2 is a direct bond or a linker; each R, RA, RB, RC, RD, Rα, and Rβ is hydrogen or a General Substituent defined herein; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the same are also provided.

    ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

    公开(公告)号:US20240381757A1

    公开(公告)日:2024-11-14

    申请号:US18606229

    申请日:2024-03-15

    Abstract: Provided is a compound having a formula of M(LA)(LB)(LC); where LA, LB and LC are each a bidentate ligand and are different from each other; M is selected from the group consisting of Ir, Os, Rh, Ru, Pt, and Pd; two or three of LA, LB and LC are optionally linked together to form a tetradentate or hexadentate ligand; LA has a structure of Formula I: where moieties A and B are each independently a monocyclic ring or a polycyclic fused ring system, where the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently C or N; Z1 and Z2 are each independently C or N; K1 and K2 are each independently a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), and Si(Rα)(Rβ); Z1 is C if K1 is not a direct bond, Z2 is C if K2 is not a direct bond; L1 is a direct bond or an organic linker; RA and RB each independently represent mono to the maximum allowable substitution, or no substitution; wherein each Rα, Rβ, RA, and RB is independently a hydrogen or a substituent selected from the group consisting deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and any two substituents can be joined or fused into a ring; with one or more conditions as defined herein.

Patent Agency Ranking